- Patent Title: Sulfonamides as inhibitors of the uptake of extracellular citrate
-
Application No.: US16467499Application Date: 2017-12-04
-
Publication No.: US10793522B2Publication Date: 2020-10-06
- Inventor: Joerg Kley , Stefan Kauschke , Alexander Pautsch , Dieter Wiedenmayer
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent David L. Kershner
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@71861bd8
- International Application: PCT/EP2017/081359 WO 20171204
- International Announcement: WO2018/104220 WO 20180614
- Main IPC: C07D211/96
- IPC: C07D211/96 ; C07D401/12 ; C07D417/12 ; A61K31/454 ; A61K31/4545 ; A61K31/445
Abstract:
The present invention relates to sulfonamides of formula (I) wherein A, R1, and R2 are as defined herein. Also disclosed are medicaments comprising the compounds of formula (I) and their use for the treatment of metabolic and/or cardiovascular diseases.
Public/Granted literature
- US20200062708A1 SULFONAMIDES AS INHIBITORS OF THE UPTAKE OF EXTRACELLULAR CITRATE Public/Granted day:2020-02-27
Information query
